| Systematic (IUPAC) name | |
|---|---|
| N-Butyl-N-[2-(4-hydroxy-1H-indol-3-yl)ethyl]butan-1-amine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 63065-89-4 |
| ATC code | ? |
| ChemSpider | 10579818 |
| Chemical data | |
| Formula | C18H28N2O |
| Mol. mass | 288.44 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| Physical data | |
| Melt. point | 74–75 °C (165–167 °F) |
| (what is this?) (verify) |
|
4-Hydroxydibutyltryptamine (4-HO-DBT) is a psychedelic drug belonging to the tryptamine family. It is found either as its crystalline hydrochloride salt or as an oily or crystalline base. 4-HO-DBT was first made by the chemist Alexander Shulgin and reported in his book TiHKAL. Shulgin reported a dosage of 20mg orally to be without effects. However this compound has subsequently been sold as a "research chemical" and anecdotal reports suggest that at higher doses 4-HO-DBT is indeed an active hallucinogen, although somewhat weaker than other similar tryptamine derivatives.
Several different isomers of this compound could potentially be made (see DBT for a fuller discussion) but of these only the isobutyl isomer 4-HO-DIBT has been synthesised (mp 152-154 °C) and was also found to be inactive at a 20mg dose.
|
|||||
|
|||||